1. Home
  2. CTSO vs YSXT Comparison

CTSO vs YSXT Comparison

Compare CTSO & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.37

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Logo YSX Tech. Co. Ltd Class A Ordinary Shares

YSXT

YSX Tech. Co. Ltd Class A Ordinary Shares

N/A

Current Price

$1.08

Market Cap

27.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
YSXT
Founded
1997
2011
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
27.7M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
CTSO
YSXT
Price
$0.37
$1.08
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
68.3K
43.2K
Earning Date
05-01-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
N/A
P/E Ratio
N/A
$5.57
Revenue Growth
48.53
N/A
52 Week Low
$0.30
$0.50
52 Week High
$1.04
$5.01

Technical Indicators

Market Signals
Indicator
CTSO
YSXT
Relative Strength Index (RSI) 47.36 55.96
Support Level $0.36 $1.01
Resistance Level $0.40 $1.14
Average True Range (ATR) 0.04 0.12
MACD -0.00 0.01
Stochastic Oscillator 58.70 70.69

Price Performance

Historical Comparison
CTSO
YSXT

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.

Share on Social Networks: